Literature DB >> 16987375

Multimodal cerebral monitoring and decompressive surgery for the treatment of severe bacterial meningitis with increased intracranial pressure.

B Baussart1, G Cheisson, M Compain, P E Leblanc, M Tadie, D Benhamou, J Duranteau.   

Abstract

Bacterial meningitis is still associated with a high mortality, mainly because of cerebral herniation as a result of increased intracranial pressure. Published data stress the necessity of an early diagnosis and immediate start of antibiotic therapy. Nevertheless, there are only few reports in which therapeutic strategy was based on the monitoring and the reduction of intracranial pressure (ICP). We report one case of bacterial meningitis caused by Neisseria meningitidis with an initial ICP value of 60 mmHg, which was treated by large hemicraniectomy and ventriculostomy, leading to a favorable neurological long-term result. The surgical decision was accelerated by an accurate ICP evaluation based on cerebral monitoring [transcranial Doppler ultrasonography (TCD) and intracranial ICP-device]. In selected patients with bacterial meningitis and clinical and radiological evidence of elevated ICP, cerebral monitoring and aggressive reduction of ICP may be crucial to improve survival and neurological outcome. When maximal medical ICP treatment fails to reduce severe intracranial hypertension, decompressive craniectomy should be rapidly proposed.

Entities:  

Mesh:

Year:  2006        PMID: 16987375     DOI: 10.1111/j.1399-6576.2006.01038.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  11 in total

1.  Use of corticosteroids and other adjunct therapies for acute bacterial meningitis in adults.

Authors:  Kameshwar Prasad; Nirendra Kumar Rai; Amit Kumar
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Bedside evaluation of cerebral energy metabolism in severe community-acquired bacterial meningitis.

Authors:  Frantz R Poulsen; Mette Schulz; Anne Jacobsen; Åse B Andersen; Lykke Larsen; Wilhelm Schalén; Troels H Nielsen; Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

3.  Progressive intracranial hypertension and cerebral hypoperfusion in a fatal case of cerebral aspergilloma.

Authors:  Linea Natalie Toksvang; Ronni R Plovsing; Ronan M G Berg
Journal:  BMJ Case Rep       Date:  2014-06-06

4.  Fulminant Meningoencephalitis as the First Clinical Sign of an Invasive Pituitary Macroadenoma.

Authors:  T Robert; A Sajadi; A Uské; M Levivier; J Bloch
Journal:  Case Rep Neurol       Date:  2010-11-03

5.  Lumbar drainage for the treatment of severe bacterial meningitis.

Authors:  Yasser B Abulhasan; Hosam Al-Jehani; Marie-Anne Valiquette; Anne McManus; Mylène Dolan-Cake; Omar Ayoub; Mark Angle; Jeanne Teitelbaum
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

6.  Decompressive craniectomy following brain injury: factors important to patient outcome.

Authors:  Patrick O Eghwrudjakpor; Akaribari B Allison
Journal:  Libyan J Med       Date:  2010-01-07       Impact factor: 1.657

7.  Invasive pressure monitoring saves from tuberculous meningitis with fulminant generalized brain edema.

Authors:  George Trendelenburg; Daniel Jussen; Steffen Grimmer; Wibke Jakob; Nicola E Hiemann; Peter Horn
Journal:  Front Neurol       Date:  2011-11-15       Impact factor: 4.003

Review 8.  Neurological susceptibility to a skull defect.

Authors:  Stephen Honeybul
Journal:  Surg Neurol Int       Date:  2014-06-04

9.  Successful management of severe neuroinvasive eastern equine encephalitis.

Authors:  Linda C Wendell; N Stevenson Potter; Julie L Roth; Stephen P Salloway; Bradford B Thompson
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.532

10.  Neuro-intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: an intervention-control study.

Authors:  Martin Glimåker; Bibi Johansson; Halla Halldorsdottir; Michael Wanecek; Adrian Elmi-Terander; Per Hamid Ghatan; Lars Lindquist; Bo Michael Bellander
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.